Shangzhi Cao
机构：Shanghai Traditional Chinese Medicine Hospital
发表论文 6 篇 · 总被引 27 次 · h-index 2
代表论文
- Performance evaluation and clinical validation of optimized nucleotide MALDI-TOF-MS for mycobacterial identification (2022 · Frontiers in Cellular and Infection Microbiology · 被引 23)
- Spectral CT based radiomics for predicting brain metastases in patients with lung cancer (2024 · International Journal of Radiation Research · 被引 2)
- RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patients (2022 · Frontiers in Oncology · 被引 1)
- Genomic analysis in NF2 meningiomas: Does co-mutation suggest new subgroups? (2023 · Journal of Clinical Oncology)
- Development and validation of a novel HER2RI assay for predicting the risk of recurrence and survival in HER2-positive early breast cancer (2022 · Research Square)
- 383P A mass spectrometry-based assay for molecular profiling of gliomas and its validation on real-world clinical samples (2020 · Annals of Oncology)